Matrix Partners China — Full Portfolio
9 tracked investments · listed companies and verified rows first
Grandomics develops third-generation sequencing services and precision genomic medicine solutions for medical diagnostics, plant and animal breeding, and species conservation.
AgTechAI & Machine LearningBiotechData & InfrastructureDigital HealthMedical DevicesBeijing, CN
汪德鹏(CEO and Head of Technology Services BU)王洋(Executive Vice President and Chief Sequencing Technology Officer)赵云龙(Chief Operating Officer)
Co-investorsVitalbridge CapitalMarathon Venture Partners
Bota offers engineered protein solutions through strain optimization and screening, leveraging proprietary datasets to increase protein yield while reducing production costs for industrial biotech applications.
Advanced ManufacturingBiotechDeep TechFoodTechNew Materials
Dr. Cheryl Cui(CEO)
Co-investorsHongShan Capital GroupNSG VenturesSource Code CapitalSherpa Healthcare Partners
Dao Foods is an investment and advocacy firm that funds and mentors plant-based and alternative protein companies focused on or serving the Chinese market.
AgTechClimate TechFoodTechImpact & Social Good
Tao Zhang(Co-Founder)inAlbert Tseng(Co-Founder)in
Co-investorsUnovis Asset ManagementBluestein VenturesBuilders VCCongruent VenturesJoy CapitalNàdarra Ventures+4 more
Fabric is a venture capital firm backing Web3 and AI-focused companies from pre-seed to growth stage, with a thesis grounded in building human-centric applications for the machine economy.
AI & Machine LearningCrypto & Web3Deep TechFintechLondon, GB
Richard(Co-founder)Anil(Co-founder)Alain(Co-founder)Max
Co-investorsFirestartrPeakAccelerator VenturesCambridge AssociatesDN CapitalEIF+4 more
Nutshell provides customer relationship management and sales software designed for small businesses to increase revenue and improve team adoption of sales and marketing tools.
Enterprise SoftwareMarketing TechSaaSSales TechAnn Arbor, US
Andy Fowler(Co-founder)inGuy Suter(Co-founder)inIan Berry(Co-founder)in
Co-investorsID VenturesService Provider Capital
PingCAP develops TiDB, a cloud-native distributed SQL database built for scalability, strong consistency, and high availability.
Cloud ComputingData & InfrastructureDeveloper ToolsEnterprise SoftwareFintech
Co-investorsChina Growth CapitalCoatue ManagementMorningside Venture Capital LimitedAccess Technology VenturesGGV CapitalJeneration Capital+3 more
Rgenta develops orally available small molecule therapies that target RNA to address diseases previously considered undruggable, with programs in oncology (targeting proteins such as MYB in solid tumors and hematologic cancers) and central nervous system repeat expansion disorders like Huntington's disease.
AI & Machine LearningBiotechDeep TechHealthtechCambridge, US
Travis Wager(Co-founder, President and CSO)inHualin Simon Xi(Executive Officer, Director)Zhiping Weng(Co-founder)inSimon Xi(Co-founder and CEO)inJackie Walling(CMO)Debasish Roychowdhury(Director)
Co-investorsDelos CapitalVivo CapitalAMR Action FundBoehringer Ingelheim Venture FundKorea Investment PartnersLilly Asia Ventures+1 more
SemiDrive designs automotive-grade processors for intelligent vehicle cabins, integrating CPU, GPU, AI accelerators, and video processing capabilities.
AI & Machine LearningIoTSemiconductorsBeijing, CN
Co-investorsLenovo Capital and Incubator Group (LCIG)Vertex Ventures ChinaSequoia CapitalShanghai STVC GroupVertex VenturesWalden International
Tallac Therapeutics is a clinical-stage biopharmaceutical company developing oligonucleotide-based antibody conjugates (TRAAC candidates) designed to deliver immune-activating agents to tumor microenvironments for oncology indications.
BiotechHealthtechMedical DevicesBurlingame, US
Hong Wan(Executive Officer, Director)in
BoardRan Geng(Director)Michael Carusi(Director)Isaac Cheng(Director)Christine Brennan(Director)Corey Goodman(Director)in
Co-investorsLightstone VenturesMRL Ventures FundvenBio PartnersvenBio Global Strategic
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.